Skip to main content
. 2019 Feb 28;37(13):1051–1061. doi: 10.1200/JCO.18.02031

FIG 1.

FIG 1.

Patient disposition. Safety was assessed using the full analysis set population (FAS). Arm P, placebo; Arm V, PROSTVAC; Arm VG, PROSTVAC + granulocyte-macrophage colony-stimulating factor; ITT, intention-to-treat population, LTFU, long-term follow-up.